Production, Labeling, Release by a Qualified Tender - 141647409

Procurement Summary

Country: Poland

Summary: Production, Labeling, Release by a Qualified Person (Confirming Compliance with Gmp and Quality Assurance Requirements; Qa/Qp Release), Storage, Transport Along With...

Deadline: 26 Jun 2026

Posting Date: 20 May 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 141647409

Document Ref. No.: 343374-2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

73100000 - Research and experimental development services
33600000 - Pharmaceutical products

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Production, labeling, release by a Qualified Person (confirming compliance with GMP and Quality Assurance requirements; QA/QP release), storage, transport along with... Manufacturing, labeling, release service by Qualified Person (confirming compliance with GMP and Quality Assurance requirements; QA/QP release), storage, transport including delivery on the day of the patient's visit, disposal and comprehensive documentation preparation (IMPD/IB) of the Subject Medicinal Product containing the active substance Psilocybin and Comparators (SSRI) (...) The subject of this order is the service of manufacturing, labeling and release by a Qualified Person (confirming compliance with GMP requirements and with scope of Quality Assurance; QA/QP release), storage, transport including delivery on the day of the patient's visit, disposal and comprehensive documentation (IMPD/IB) of the Investigational Medicinal Product containing the substance (...) 1. Manufacturing service, labeling, release by a Qualified Person (confirming compliance with GMP and Quality Assurance requirements; QA/QP release), storage, transport with delivery on the day of the patient's visit, disposal and comprehensive development documentation (IMPD/IB) of the Investigational Medicinal Product containing the active substance Psilocybin and Comparators (SSRI) for the purposes of implementing a non-commercial clinical trial project in one research center entitled: "Randomized, open-label, controlled study to evaluate the effectiveness and safety of Psilocybin in the treatment of refractory depression, administered with SSRIs or after gradual discontinuation...
Document Type: Contract Notice Reference Number: AEZ/S-107/2025 Contract Type: services Authority Type: body-pl Doc Title: Manufacturing, labeling and release service by a Qualified Person (confirming compliance with GMP requirements and the scope of Quality Assurance; QA/QP release), storage, transport including delivery on the day of the patient's visit, disposal and comprehensive documentation preparation (IMPD/IB) of the Investigational Medicinal Product containing the active substance Psilocybin and Comparators (SSRI) (...) Dispatch Date: 2026-05-19 Publish Date: 2026-05-20 Submission Date: 2026-06-26

Documents

 Tender Notice